Saturday 17 October 2026 Export IONS’s income statement to Excel — free account

Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $943.7 million, up 33.8% from fiscal 2024. In the quarter to June 2026, revenue fell 40.7%, EPS fell 188.5%, free cash flow grew 299.3% and total debt rose 116.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

42.94 1.18 −2.67%

Follow IONS

Alert me

Market cap: $7.3B
P/E: 0.0×
Fwd P/E: −20.8×
Dividend yield: —
F-score: 4/9
Altman Z: 2.12
Beneish M: −3.13
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(40.04%)	(70.80%)	(67.62%)	(105.50%)
Piotroski F-Score Full definition →		5	4	3	2
ROA Full definition →		(8.39%)	(11.69%)	(10.44%)	(18.90%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(14.89%)	(16.35%)	(13.84%)	(24.25%)
Average Days of Receivables Full definition →		9.29	25.55	25.42	24.57
Free Cash Flow per Share Full definition →		(1.94)	(2.04)	(5.93)	(3.43)
Free Cash Flow Full definition →		(309.48)	(325.67)	(977.73)	(567.50)
Capital Expenditures Full definition →		(62.47)	(57.08)	(67.10)	(71.07)
Other line items
Cash ROIC Full definition →		(8.96%)	(6.58%)	(26.01%)	(14.76%)
Accounts Receivable Turnover Full definition →		45.47	11.93	18.66	15.69
Accounts Payable Turnover Full definition →		1.01	0.45	0.80	0.45
Inventory Turnover Full definition →		0.61	1.41	2.04	0.54
Average Days of Payables Full definition →		443.85	644.29	545.12	1,087.09
Days of Inventory on Hand Full definition →		324.38	230.53	116.38	1,158.40
Tax Rate Full definition →		(0.01)	0.00	0.01	0.01
Research and Development Expense of Revenue Full definition →		91.16%	97.02%	87.42%	105.79%
Selling, General and Administrative Expense of Revenue Full definition →		36.38%	41.74%	44.22%	60.38%
Share Based Compensation of Revenue Full definition →		13.10%	14.19%	13.93%	18.69%
Interest Coverage Full definition →		(3.06)	(4.22)	(3.91)	(6.64)
Operating CF/Net income Full definition →		0.96	0.70	2.79	0.88
Depreciation/Fixed assets Full definition →		0.00	0.05	0.07	0.09
Capex/Depreciation Full definition →		223.91	(9.73)	(7.03)	(4.93)
Revenue per Share Full definition →		6.05	5.90	6.42	5.28
Operating CF per Share Full definition →		(1.55)	(1.68)	(5.52)	(3.00)
Capex per Share Full definition →		(0.39)	(0.36)	(0.41)	(0.43)
Capex to Sales Full definition →		0.06	0.06	0.06	0.08

Show all line items

Columns are period end dates

Stockrow Weekly